6-KThe Wire
Sanofi files 6-K
Filed Apr 27, 2026 · 2mo ago · Accession 0001193125-26-180848
Plain English
Sanofi announced several positive regulatory updates in April 2026, including US approvals for Tzield and Dupixent, and a European recommendation for Cenrifki.
Filing details
- Company
- Sanofi
- Ticker
- SNY
- CIK
- 1121404
- Form type
- 6-K
- Filing date
- Apr 27, 2026
- Report date
- Apr 27, 2026
- Document
- d137048d6k.htm
- Size
- 146 KB